Nikanjam, Mina <br/><br/>
Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Mar 2015 
 - 495-503 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-014-2667-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Child<br/>Child, Preschool<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Creatinine--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Monte Carlo Method<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Tissue Distribution<br/>Young Adult